Efficacy of Immunotherapy in Second-Line Treatment of KRAS-Mutated Patients with Non-Small-Cell Lung Cancer—Data from Daily Practice

Background The implementation of next-generation sequencing (NGS) into daily practice allows for the identification of a greater number of molecular abnormalities. We aimed to confirm the benefits of immunotherapy in the group of patients with KRAS aberrations treated within clinical practice. Metho...

Descripción completa

Detalles Bibliográficos
Autores principales: Knetki-Wróblewska, Magdalena, Tabor, Sylwia, Płużański, Adam, Lewandowska, Zofia, Tysarowski, Andrzej, Pawlik, Hubert, Kowalski, Dariusz M., Krzakowski, Maciej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9858515/
https://www.ncbi.nlm.nih.gov/pubmed/36661686
http://dx.doi.org/10.3390/curroncol30010037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9858515/
https://www.ncbi.nlm.nih.gov/pubmed/36661686
http://dx.doi.org/10.3390/curroncol30010037

Ejemplares similares